NVD-200

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNVD-200
Drug Alias Nameanti-SARS-CoV-2 spike protein mAb (Invivyd)VYD-222 + adintrevimab (Invivyd)NVD-200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvivyd Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvivyd Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A